Posted by Michael Wonder on 04 Apr 2023
Daridorexant for the treatment of patients with insomnia disorder
3 April 2023 - The Department of Health and Social Care has asked the NICE to produce guidance on the use of daridorexant in the NHS in England.
Daridorexant is not recommended for the treatment of adults with insomnia in adults with symptoms for at least 3 months and a considerable effect on daytime functioning.
